secwatch / observer
8-K filed May 24, 2023, 7:59 PM ET CIK 0000727207
other material confidence high sentiment neutral materiality 0.50

Accelerate Diagnostics shareholders approve 250M share increase, reverse split, and equity plan expansion

Accelerate Diagnostics, Inc

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Accelerate Diagnostics, Inc: Increased total authorized shares of capital stock from 205,000,000 to 455,000,000, with common stock increased from 200,000,000 to 450,000,000 and preferred stock unchanged at 5,000,000 (effective 2023-05-23).

Change
charter amendment
Effective
2023-05-23
Exact text from the filing
On May 23, 2023, Accelerate Diagnostics, Inc. (the “Company”) filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to increase the total number of authorized shares of the Company’s capital stock to 455,000,000 shares, of which 450,000,000 shares are designated as common stock and 5,000,000 shares are designated as preferred stock.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Accelerate Diagnostics, Inc shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2023-05-19 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-05-19
Exact text from the filing
Proposal No. 6 – Ratification of Independent Registered Public Accounting Firm Votes For Votes Against Abstentions Broker Non-Votes 69,820,039 426,721 187,996 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Accelerate Diagnostics, Inc shareholders approved Approval of Certificate Amendment to effect a reverse stock split at the 2023-05-19 meeting.

Proposal
reverse split
Outcome
passed
Meeting
2023-05-19
Exact text from the filing
Proposal No. 4 – Approval of Certificate Amendment to the Certificate of Incorporation to Effect a Reverse Stock Split Votes For Votes Against Abstentions Broker Non-Votes 66,920,245 3,390,632 123,879 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Accelerate Diagnostics, Inc shareholders approved Approval of Plan Amendment to increase authorized shares under the 2022 Incentive Plan at the 2023-05-19 meeting.

Proposal
equity plan
Outcome
passed
Meeting
2023-05-19
Exact text from the filing
Proposal No. 3 – Approval of Plan Amendment Votes For Votes Against Abstentions Broker Non-Votes 65,510,097 4,674,623 250,036 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Accelerate Diagnostics, Inc shareholders approved Election of 9 directors at the 2023-05-19 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-05-19
Exact text from the filing
On May 19, 2023, the Company held its 2023 Annual Meeting of Shareholders (the “Annual Meeting”). At the Annual Meeting, the Company’s shareholders: (1) elected 9 directors
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Accelerate Diagnostics, Inc shareholders approved Approval of Nasdaq Rule 5635(d) Proposal regarding issuance of common stock below minimum price at the 2023-05-19 meeting.

Outcome
passed
Meeting
2023-05-19
Exact text from the filing
Proposal No. 5 – Approval of Nasdaq Rule 5635(d) Proposal Votes For Votes Against Abstentions Broker Non-Votes 67,080,356 3,202,778 151,622 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Accelerate Diagnostics, Inc shareholders approved Approval of Certificate Amendment to Increase Authorized Shares at the 2023-05-19 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2023-05-19
Exact text from the filing
Proposal No. 2 – Approval of Certificate Amendment to the Certificate of Incorporation to Increase Authorized Shares Votes For Votes Against Abstentions Broker Non-Votes 65,723,737 4,583,940 127,079 0
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001104659-23-064180
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.